(Q37593877)
Statements
1 reference
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). (English)
1 reference
Steven R Alberts
1 reference
Aminah Jatoi
1 reference
Shaker R Dakhil
1 reference
Nathan R Foster
1 reference
Cynthia Ma
1 reference
Kendrith M Rowland
1 reference
Dennis F Moore
1 reference
Anthony J Jaslowski
1 reference
Sachdev P Thomas
1 reference
Mark D Hauge
1 reference
Patrick J Flynn
1 reference
Philip J Stella
1 reference
1 reference
1 reference
Identifiers
1 reference